Cargando…

Does cancer deserve special treatment when health technologies are prioritized?

Despite most new cancer treatments having relatively high costs and low health benefits, they are often funded ahead of treatments for other illnesses. And yet, according to the article by Dan Greenberg and colleagues, most Israeli oncologists and family physicians think that new cancer treatments s...

Descripción completa

Detalles Bibliográficos
Autor principal: Hansen, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843515/
https://www.ncbi.nlm.nih.gov/pubmed/24245831
http://dx.doi.org/10.1186/2045-4015-2-45
_version_ 1782293057106870272
author Hansen, Paul
author_facet Hansen, Paul
author_sort Hansen, Paul
collection PubMed
description Despite most new cancer treatments having relatively high costs and low health benefits, they are often funded ahead of treatments for other illnesses. And yet, according to the article by Dan Greenberg and colleagues, most Israeli oncologists and family physicians think that new cancer treatments should not receive such a high priority and that cost-effectiveness data should be used to support funding decisions. In this commentary, I point out that the increasing pressure worldwide when prioritizing health technologies to widen the scope of the benefits that are recognized beyond just narrowly-defined health benefits would almost certainly include the special characteristics of cancer. Future research would be worthwhile into how the criteria for prioritizing technologies should be incorporated into prioritization frameworks in practice, including, in particular, how to resolve the inherent trade-offs. This is a commentary on http://www.ijhpr.org/content/2/2/44/
format Online
Article
Text
id pubmed-3843515
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38435152013-11-30 Does cancer deserve special treatment when health technologies are prioritized? Hansen, Paul Isr J Health Policy Res Commentary Despite most new cancer treatments having relatively high costs and low health benefits, they are often funded ahead of treatments for other illnesses. And yet, according to the article by Dan Greenberg and colleagues, most Israeli oncologists and family physicians think that new cancer treatments should not receive such a high priority and that cost-effectiveness data should be used to support funding decisions. In this commentary, I point out that the increasing pressure worldwide when prioritizing health technologies to widen the scope of the benefits that are recognized beyond just narrowly-defined health benefits would almost certainly include the special characteristics of cancer. Future research would be worthwhile into how the criteria for prioritizing technologies should be incorporated into prioritization frameworks in practice, including, in particular, how to resolve the inherent trade-offs. This is a commentary on http://www.ijhpr.org/content/2/2/44/ BioMed Central 2013-11-18 /pmc/articles/PMC3843515/ /pubmed/24245831 http://dx.doi.org/10.1186/2045-4015-2-45 Text en Copyright © 2013 Hansen; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Hansen, Paul
Does cancer deserve special treatment when health technologies are prioritized?
title Does cancer deserve special treatment when health technologies are prioritized?
title_full Does cancer deserve special treatment when health technologies are prioritized?
title_fullStr Does cancer deserve special treatment when health technologies are prioritized?
title_full_unstemmed Does cancer deserve special treatment when health technologies are prioritized?
title_short Does cancer deserve special treatment when health technologies are prioritized?
title_sort does cancer deserve special treatment when health technologies are prioritized?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843515/
https://www.ncbi.nlm.nih.gov/pubmed/24245831
http://dx.doi.org/10.1186/2045-4015-2-45
work_keys_str_mv AT hansenpaul doescancerdeservespecialtreatmentwhenhealthtechnologiesareprioritized